Cees J. A. van Echteld

ABX-CRO Advanced Pharmaceutical Services (Germany) — Germany

Medicine · Health Sciences

34h-index5.5kcitations124works2.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Advanced MRI Techniques and Applications(51), Cardiac Imaging and Diagnostics(21), Lipid Membrane Structure and Behavior(21), Cardiac electrophysiology and arrhythmias(20), Cardiac Ischemia and Reperfusion(13)

Publications124 total

Immune Response to Molecular Radiotherapy with <sup>177</sup> Lu-DOTATOC: Predictive Value of Blood Cell Counts for Therapy Outcome
Cancer Biotherapy and Radiopharmaceuticals·2024· 1 citedOpen Access
Safety and Efficacy of<i>Para</i>-Aminohippurate Coinfusion for Renal Protection During Peptide Receptor Radiotherapy in Patients with Neuroendocrine Tumors
Journal of Nuclear Medicine·2024· 4 citedOpen Access
Uptake of 68Ga-DOTATATE and 68Ga-DOTATOC in Primary Neuroendocrine Tumors, Metastases, and Normal Liver Tissue: Is There a Significant Difference?
2024· 3 citedOpen Access
Retrospective phase II study of efficacy and safety of <sup>177</sup>Lu-DOTATOC peptide receptor radiotherapy in patients with advanced neuroendocrine tumours.
Journal of Clinical Oncology·2016
[<sup>177</sup>Lu-DOTA]<sup>0</sup>-D-Phe<sup>1</sup>-Tyr<sup>3</sup>-Octreotide (<sup>177</sup>Lu-DOTATOC) For Peptide Receptor Radiotherapy in Patients with Advanced Neuroendocrine Tumours: A Phase-II Study
Theranostics·2016· 100 citedOpen Access
TOC) For Peptide Receptor Radiotherapy in Patients with Advanced Neuroendocrine Tumours: A Phase-II
2016
2269 [177Lu-DOTA]-D-Phe1-Tyr3-octreotide (177Lu-DOTATOC) for peptide receptor radiotherapy in patients with advanced neuroendocrine tumours: A retrospective phase II study of efficacy and safety
European Journal of Cancer·2015
23Na chemical shift imaging and Gd enhancement of myocardial edema
International journal of cardiac imaging·2012· 11 citedOpen Access
Quantitative T 2 * assessment of acute and chronic myocardial ischemia/reperfusion injury in mice
Magnetic Resonance Materials in Physics Biology and Medicine·2012· 20 citedOpen Access
A View on Imaging in Drug Research and Development for Respiratory Diseases
Journal of Pharmacology and Experimental Therapeutics·2011· 19 cited
(A) Survival rates of mice prenatally treated with saline (white circle), fluvoxamine (gray triangle) or fluoxetine (black square) from 1 to 20 days after birth
Figshare·2011Open Access
Evaluation of infarcted murine heart function: comparison of prospectively triggered with self‐gated MRI
NMR in Biomedicine·2010· 36 cited
The time window of MRI of murine atherosclerotic plaques after administration of CB2 receptor targeted micelles: inter‐scan variability and relation between plaque signal intensity increase and gadolinium content of inversion recovery prepared versus non‐prepared fast spin echo
NMR in Biomedicine·2010· 6 cited
Characterization and In Vitro and In Vivo Testing of CB2-Receptor- and NGAL-Targeted Paramagnetic Micelles for Molecular MRI of Vulnerable Atherosclerotic Plaque
Molecular Imaging and Biology·2010· 17 cited
Recent developments and new perspectives on imaging of atherosclerotic plaque: role of anatomical, cellular and molecular MRI Part I and II
International journal of cardiac imaging·2010· 4 cited
Antioxidant treatment attenuates pulmonary arterial hypertension-induced heart failure
American Journal of Physiology-Heart and Circulatory Physiology·2010· 117 cited
Recent developments and new perspectives on imaging of atherosclerotic plaque: role of anatomical, cellular and molecular MRI part III
International journal of cardiac imaging·2010· 7 cited
Negative MR contrast caused by USPIO uptake in lymph nodes may lead to false positive observations with in vivo visualization of murine atherosclerotic plaque
Atherosclerosis·2009· 7 cited
Correction: Modulation of Serotonin Transporter Function during Fetal Development Causes Dilated Heart Cardiomyopathy and Lifelong Behavioral Abnormalities
PLoS ONE·2009· 3 citedOpen Access
Targeted Deletion of Nuclear Factor κB p50 Enhances Cardiac Remodeling and Dysfunction Following Myocardial Infarction
Circulation Research·2009· 105 cited
page 1 of 7Next →

Frequent Co-authors

Ben de Kruijff(12), Marcel G.J. Nederhoff(11), J. de Gier(10), Arie J. Verkleij(8), T. J. C. Ruigrok(6), Jan G. Van Emous(5), J. Leunissen‐Bijvelt(5), Klaas Nicolay(5), Gerard Pasterkamp(4), P.C. Noordam(4), Maurits A. Jansen(4), Michiel ten Hove(4), Ferdi A. van Dorsten(4), Jeroen A. L. Jeneson(3), W.J. Gerritsen(3), Pieter A. Doevendans(3), Ben de Kruijff(3), J. Onno van Dobbenburgh(3), Leo Timmers(2), J. Karlijn van Keulen(2)